Table 2 Proportion of patients receiving different 5-FU- and capecitabine-based chemotherapeutic regimens
From: Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
| Treatment protocol | Patients | |
|---|---|---|
| n | % | |
| 5-FU based treatment regimen | 196 | |
| 5-FU bolus | 3 | 1.5 |
| 24-h continuous infusion | 9 | 4.6 |
| 5-FU + folinic acid + oxaliplatin | 118 | 60.2 |
| 5-FU + folinic acid + irinotecan | 37 | 18.9 |
| Other 5-FU combo therapy | 29 | 14.8 |
| Capecitabine based treatment regimen | 331 | |
| Capecitabine monotherapy | 11 | 3.3 |
| Capecitabine + oxaliplatin | 310 | 93.7 |
| Other capecitabine combo therapy | 10 | 3.0 |